Search

Oct 2, 2024
Vor Bio is trying to help AML patients who receive a stem cell transplant to be more amenable to follow-on therapies - they just had key PoC data
President and CEO Robert Ang describes how Vor knocks out CD33 in transplant cells before they are administered so that patients can...